King's College London

Research portal

Statins: a panacea to reduce mortality in patients undergoing liver transplantation for hepatocellular carcinoma?

Research output: Contribution to journalEditorialpeer-review

Debbie L Shawcross, Abid Suddle

Original languageEnglish
JournalLiver Transplantation
Early online date27 Nov 2021
DOIs
Accepted/In press2021
E-pub ahead of print27 Nov 2021

Bibliographical note

This article is protected by copyright. All rights reserved.

Documents

King's Authors

Abstract

In Greek mythology Panacea was the goddess of universal remedy or health. In literary terms a panacea represents a solution to solve all ills and there are few drugs that can claim such an accolade. One drug class that has claimed to be a panacea in adults at increased risk of cardiovascular disease are statins. Since their FDA approval in the late 1980s, statins have revolutionised the management of hypercholesterolemia.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454